311 related articles for article (PubMed ID: 10395825)
21. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
22. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
Solomaha E; Szeto FL; Yousef MA; Palfrey HC
J Biol Chem; 2005 Jun; 280(24):23147-56. PubMed ID: 15834155
[TBL] [Abstract][Full Text] [Related]
23. Mnb/Dyrk1A phosphorylation regulates the interaction of dynamin 1 with SH3 domain-containing proteins.
Huang Y; Chen-Hwang MC; Dolios G; Murakami N; Padovan JC; Wang R; Hwang YW
Biochemistry; 2004 Aug; 43(31):10173-85. PubMed ID: 15287745
[TBL] [Abstract][Full Text] [Related]
24. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
25. Modelling of the complex between a 15-residue peptide from mSos2 and the N-terminal SH3 domain of Grb2 by molecular-dynamics simulation.
Calero S; Lago S; van Gunsteren WF; Daura X
Chem Biodivers; 2004 Mar; 1(3):505-19. PubMed ID: 17191865
[TBL] [Abstract][Full Text] [Related]
26. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos.
Terasawa H; Kohda D; Hatanaka H; Tsuchiya S; Ogura K; Nagata K; Ishii S; Mandiyan V; Ullrich A; Schlessinger J
Nat Struct Biol; 1994 Dec; 1(12):891-7. PubMed ID: 7773778
[TBL] [Abstract][Full Text] [Related]
27. A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment.
Ando A; Yonezawa K; Gout I; Nakata T; Ueda H; Hara K; Kitamura Y; Noda Y; Takenawa T; Hirokawa N
EMBO J; 1994 Jul; 13(13):3033-8. PubMed ID: 8039498
[TBL] [Abstract][Full Text] [Related]
28. SH3 binding domains in the dopamine D4 receptor.
Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the amphiphysin-2 SH3 domain and its role in the prevention of dynamin ring formation.
Owen DJ; Wigge P; Vallis Y; Moore JD; Evans PR; McMahon HT
EMBO J; 1998 Sep; 17(18):5273-85. PubMed ID: 9736607
[TBL] [Abstract][Full Text] [Related]
30. Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs.
Cussac D; Frech M; Chardin P
EMBO J; 1994 Sep; 13(17):4011-21. PubMed ID: 7521298
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.
Russo K; Di Stasio E; Macchia G; Rosa G; Brancaccio A; Petrucci TC
Biochem Biophys Res Commun; 2000 Jul; 274(1):93-8. PubMed ID: 10903901
[TBL] [Abstract][Full Text] [Related]
32. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
33. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
34. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
35. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
36. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
[TBL] [Abstract][Full Text] [Related]
37. The Grb2 binding domain of mSos1 is not required for downstream signal transduction.
Wang W; Fisher EM; Jia Q; Dunn JM; Porfiri E; Downward J; Egan SE
Nat Genet; 1995 Jul; 10(3):294-300. PubMed ID: 7670467
[TBL] [Abstract][Full Text] [Related]
38. Prion protein interaction with the C-terminal SH3 domain of Grb2 studied using NMR and optical spectroscopy.
Lysek DA; Wüthrich K
Biochemistry; 2004 Aug; 43(32):10393-9. PubMed ID: 15301538
[TBL] [Abstract][Full Text] [Related]
39. A non-canonical Grb2-PLC-gamma1-Sos cascade triggered by lipovitellin 1, an apolipoprotein B homologue.
Browaeys-Poly E; Broutin I; Antoine AF; Marin M; Lescuyer A; Vilain JP; Ducruix A; Cailliau K
Cell Signal; 2007 Dec; 19(12):2540-8. PubMed ID: 17869481
[TBL] [Abstract][Full Text] [Related]
40. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
